HER2-targeted therapies for salivary gland cancers.
Filippini DM, Pagani R, Tober N, Lorini L, Riefolo M, Molinari G, Burato A, Alfieri S, Bossi P, Presutti L.
Filippini DM, et al. Among authors: burato a.
Oral Oncol. 2024 Jan;148:106612. doi: 10.1016/j.oraloncology.2023.106612. Epub 2023 Nov 27.
Oral Oncol. 2024.
PMID: 38016228
Free article.
Review.